290 related articles for article (PubMed ID: 15868376)
21. Characterizations of irofulven cytotoxicity in combination with cisplatin and oxaliplatin in human colon, breast, and ovarian cancer cells.
Serova M; Calvo F; Lokiec F; Koeppel F; Poindessous V; Larsen AK; Laar ES; Waters SJ; Cvitkovic E; Raymond E
Cancer Chemother Pharmacol; 2006 Apr; 57(4):491-9. PubMed ID: 16075278
[TBL] [Abstract][Full Text] [Related]
22. In vitro evaluation of flavopiridol, a novel cell cycle inhibitor, in bladder cancer.
Chien M; Astumian M; Liebowitz D; Rinker-Schaeffer C; Stadler WM
Cancer Chemother Pharmacol; 1999; 44(1):81-7. PubMed ID: 10367753
[TBL] [Abstract][Full Text] [Related]
23. Myricetin and methyl eugenol combination enhances the anticancer activity, cell cycle arrest and apoptosis induction of cis-platin against HeLa cervical cancer cell lines.
Yi JL; Shi S; Shen YL; Wang L; Chen HY; Zhu J; Ding Y
Int J Clin Exp Pathol; 2015; 8(2):1116-27. PubMed ID: 25972998
[TBL] [Abstract][Full Text] [Related]
24. Characterization of a human colorectal carcinoma cell line with acquired resistance to flavopiridol.
Smith V; Raynaud F; Workman P; Kelland LR
Mol Pharmacol; 2001 Nov; 60(5):885-93. PubMed ID: 11641415
[TBL] [Abstract][Full Text] [Related]
25. CDK4/6 inhibition presents as a therapeutic option for paediatric and adult germ cell tumours and induces cell cycle arrest and apoptosis via canonical and non-canonical mechanisms.
Skowron MA; Vermeulen M; Winkelhausen A; Becker TK; Bremmer F; Petzsch P; Schönberger S; Calaminus G; Köhrer K; Albers P; Nettersheim D
Br J Cancer; 2020 Aug; 123(3):378-391. PubMed ID: 32418994
[TBL] [Abstract][Full Text] [Related]
26. 5-Azacitidine Exerts Prolonged Pro-Apoptotic Effects and Overcomes Cisplatin-Resistance in Non-Seminomatous Germ Cell Tumor Cells.
Oing C; Verem I; Mansour WY; Bokemeyer C; Dyshlovoy S; Honecker F
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30577584
[TBL] [Abstract][Full Text] [Related]
27. Cell cycle-independent induction of apoptosis by the anti-tumor drug Flavopiridol in endothelial cells.
Brüsselbach S; Nettelbeck DM; Sedlacek HH; Müller R
Int J Cancer; 1998 Jul; 77(1):146-52. PubMed ID: 9639406
[TBL] [Abstract][Full Text] [Related]
28. [Synergism of antitumor effects on ovarian carcinoma using autocatalytic caspase-3 combined with flavopiridol].
Song Y; Shen K; Xu F
Zhonghua Fu Chan Ke Za Zhi; 2010 Oct; 45(10):781-6. PubMed ID: 21176562
[TBL] [Abstract][Full Text] [Related]
29. [Therapeutic effect of flavopiridol, a small molecular cyclin-dependent kinase inhibitor, in human ovarian carcinoma].
Song Y; Shen K; Tang PP
Zhonghua Fu Chan Ke Za Zhi; 2007 Nov; 42(11):761-4. PubMed ID: 18307904
[TBL] [Abstract][Full Text] [Related]
30. Cisplatin inhibits paclitaxel-induced apoptosis in cisplatin-resistant ovarian cancer cell lines: possible explanation for failure of combination therapy.
Judson PL; Watson JM; Gehrig PA; Fowler WC; Haskill JS
Cancer Res; 1999 May; 59(10):2425-32. PubMed ID: 10344753
[TBL] [Abstract][Full Text] [Related]
31. Enhancement of depsipeptide-mediated apoptosis of lung or esophageal cancer cells by flavopiridol: activation of the mitochondria-dependent death-signaling pathway.
Nguyen DM; Schrump WD; Tsai WS; Chen A; Stewart JH; Steiner F; Schrump DS
J Thorac Cardiovasc Surg; 2003 May; 125(5):1132-42. PubMed ID: 12771887
[TBL] [Abstract][Full Text] [Related]
32. Apoptosis induced by 5-fluorouracil, cisplatin and paclitaxel are associated with p53 gene status in gastric cancer cell lines.
Matsuhashi N; Saio M; Matsuo A; Sugiyama Y; Saji S
Int J Oncol; 2005 Jun; 26(6):1563-7. PubMed ID: 15870870
[TBL] [Abstract][Full Text] [Related]
33. Flavopiridol sensitivity of cancer cells isolated from ascites and pleural fluids.
Richard C; Matthews D; Duivenvoorden W; Yau J; Wright PS; Th'ng JP
Clin Cancer Res; 2005 May; 11(9):3523-9. PubMed ID: 15867255
[TBL] [Abstract][Full Text] [Related]
34. Sequential dependent enhancement of caspase activation and apoptosis by flavopiridol on paclitaxel-treated human gastric and breast cancer cells.
Motwani M; Delohery TM; Schwartz GK
Clin Cancer Res; 1999 Jul; 5(7):1876-83. PubMed ID: 10430095
[TBL] [Abstract][Full Text] [Related]
35. Cisplatin-mediated sensitivity to TRAIL-induced cell death in human granulosa tumor cells.
Woods DC; Alvarez C; Johnson AL
Gynecol Oncol; 2008 Mar; 108(3):632-40. PubMed ID: 18191995
[TBL] [Abstract][Full Text] [Related]
36. Improvement of esophageal adenocarcinoma cell and xenograft responses to radiation by targeting cyclin-dependent kinases.
Raju U; Ariga H; Koto M; Lu X; Pickett J; Valdecanas D; Mason KA; Milas L
Radiother Oncol; 2006 Aug; 80(2):185-91. PubMed ID: 16905211
[TBL] [Abstract][Full Text] [Related]
37. Sulforaphane induces cell cycle arrest by protecting RB-E2F-1 complex in epithelial ovarian cancer cells.
Bryant CS; Kumar S; Chamala S; Shah J; Pal J; Haider M; Seward S; Qazi AM; Morris R; Semaan A; Shammas MA; Steffes C; Potti RB; Prasad M; Weaver DW; Batchu RB
Mol Cancer; 2010 Mar; 9():47. PubMed ID: 20196847
[TBL] [Abstract][Full Text] [Related]
38. Potent antileukemic interactions between flavopiridol and TRAIL/Apo2L involve flavopiridol-mediated XIAP downregulation.
Rosato RR; Dai Y; Almenara JA; Maggio SC; Grant S
Leukemia; 2004 Nov; 18(11):1780-8. PubMed ID: 15385934
[TBL] [Abstract][Full Text] [Related]
39. Selective sensitization of transformed cells to flavopiridol-induced apoptosis following recruitment to S-phase.
Matranga CB; Shapiro GI
Cancer Res; 2002 Mar; 62(6):1707-17. PubMed ID: 11912144
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the cytotoxicity of the Bithionol-paclitaxel combination in a panel of human ovarian cancer cell lines.
Ayyagari VN; Diaz-Sylvester PL; Hsieh TJ; Brard L
PLoS One; 2017; 12(9):e0185111. PubMed ID: 28931042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]